Enyedy Mark J

CIK 00015869657 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001586965

Recent Transactions

50 trades

Award
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.$CRL
Common Stock
2025-06-02$135.04/sh+946→ 946 total
Award
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.$CRL
Stock Options (Right to Buy)
2025-06-02$135.04/sh+2,082→ 2,082 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2024-05-21+4,720→ 6,900 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (Right to Buy)
2024-02-12−1,100,000→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (Right to Buy)
2024-02-12−196,875→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (Right to Buy)
2024-02-12−925,000→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (Right to Buy)
2024-02-12−1,100,000→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (Right to Buy)
2024-02-12−922,400→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Common Stock
2024-02-12−584,397→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Restricted Stock Unit
2024-02-12−102,466→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Restricted Stock Unit
2024-02-12−140,357→ 0 total
Sale
ImmunoGen, Inc.
Common Stock
2024-02-05$29.28/sh−20,107→ 584,397 total
Exercise/Conversion
ImmunoGen, Inc.
Common Stock
2024-02-02+51,234→ 604,504 total
Exercise/Conversion
ImmunoGen, Inc.
Restricted Stock Unit
2024-02-02−51,234→ 102,466 total
Award
ImmunoGen, Inc.
Restricted Stock Unit
2024-02-01+140,357→ 140,357 total
Award
BIOMARIN PHARMACEUTICAL INC$BMRN
Common Stock
2023-12-27+2,180→ 2,180 total
Exercise/Conversion
ImmunoGen, Inc.
Stock Option (Right to Buy)
2023-08-04−300,000→ 0 total
Exercise/Conversion
ImmunoGen, Inc.
Stock Option (Right to Buy)
2023-08-04−21,978→ 196,875 total
Exercise/Conversion
ImmunoGen, Inc.
Stock Option (Right to Buy)
2023-08-04−782,240→ 0 total
Exercise/Conversion
ImmunoGen, Inc.
Common Stock
2023-08-04$5.25/sh+782,240→ 1,223,689 total
Sale
ImmunoGen, Inc.
Common Stock
2023-08-04$16.96/sh−992,397→ 553,270 total
Exercise/Conversion
ImmunoGen, Inc.
Common Stock
2023-08-04$4.55/sh+21,978→ 1,245,667 total
Exercise/Conversion
ImmunoGen, Inc.
Common Stock
2023-08-04$5.65/sh+300,000→ 1,545,667 total
Exercise/Conversion
ImmunoGen, Inc.
Stock Option (Right to Buy)
2023-08-03−2,760→ 782,240 total
Exercise/Conversion
ImmunoGen, Inc.
Stock Option (Right to Buy)
2023-08-03−831,147→ 218,853 total
Sale
ImmunoGen, Inc.
Common Stock
2023-08-03$16.61/sh−1,020,000→ 441,449 total
Exercise/Conversion
ImmunoGen, Inc.
Common Stock
2023-08-03$5.25/sh+2,760→ 444,209 total
Exercise/Conversion
ImmunoGen, Inc.
Common Stock
2023-08-03$4.55/sh+1,017,240→ 1,461,449 total
Exercise/Conversion
ImmunoGen, Inc.
Stock Option (Right to Buy)
2023-08-03−186,093→ 196,875 total
Exercise/Conversion
ImmunoGen, Inc.
Common Stock
2023-08-02$4.55/sh+995,157→ 1,436,606 total
Sale
ImmunoGen, Inc.
Common Stock
2023-08-02$17.45/sh−986,521→ 450,085 total
Exercise/Conversion
ImmunoGen, Inc.
Stock Option (Right to Buy)
2023-08-02−995,157→ 382,968 total
Sale
ImmunoGen, Inc.
Common Stock
2023-08-02$18.15/sh−8,636→ 441,449 total
Award
ImmunoGen, Inc.
Common Stock
2023-06-30$4.05/sh+5,241→ 441,449 total
Award
ImmunoGen, Inc.
Restricted Stock Unit
2023-02-03+153,700→ 153,700 total
Award
ImmunoGen, Inc.
Stock Option (right to buy)
2023-02-03+922,400→ 922,400 total
Disposition to Issuer
LogicBio Therapeutics, Inc.
Common Stock
2022-11-16−2,921→ 0 total
Disposition to Issuer
LogicBio Therapeutics, Inc.
Stock Option (right to buy)
2022-11-16−12,500→ 0 total
Award
ImmunoGen, Inc.
Stock Option (Right to Buy)
2022-11-14+787,500→ 1,181,250 total
Award
ImmunoGen, Inc.
Common Stock
2022-06-30$3.83/sh+3,342→ 436,208 total
Award
LogicBio Therapeutics, Inc.
Stock Option (right to buy)
2022-06-17+12,500→ 12,500 total
Award
ImmunoGen, Inc.
Stock Option (Right to Buy)
2022-05-20+393,750→ 393,750 total
Award
ImmunoGen, Inc.
Stock Option (right to buy)
2022-02-04$5.32/sh+1,100,000→ 1,100,000 total
Award
ImmunoGen, Inc.
Common Stock
2021-06-30$5.52/sh+3,849→ 432,866 total
Award
LogicBio Therapeutics, Inc.
Stock Option (right to buy)
2021-06-11+12,500→ 12,500 total
Award
ImmunoGen, Inc.
Stock Option (right to buy)
2021-02-05$7.69/sh+925,000→ 925,000 total
Exercise/Conversion
LogicBio Therapeutics, Inc.
Common Stock
2021-01-01+2,921→ 2,921 total
Exercise/Conversion
LogicBio Therapeutics, Inc.
Restricted Stock Units
2021-01-01−2,921→ 0 total
Gift
ImmunoGen, Inc.
Common Stock
2020-12-22−10,000→ 429,017 total
Award
ImmunoGen, Inc.
Common Stock
2020-06-30$3.91/sh+5,241→ 439,017 total

Companies

Recent Filings

Address

C/O FATE THERAPEUTICS, INC.; 3535 GENERAL ATOMICS COURT, SUITE 200

SAN DIEGO, CA, 92121

View on SEC.gov